Back
Esperion Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
ESPR
Esperion Therapeutics
Last Price:
2.48
Seasonality Move:
33.73%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing slight buying pressure.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.3 | Buy |
| 20-day SMA: | 2.18 | Buy |
| 50-day SMA: | 1.99 | Buy |
| 200-day SMA: | 2.22 | Buy |
| 8-day EMA: | 2.28 | Buy |
| 20-day EMA: | 2.2 | Buy |
| 50-day EMA: | 2.09 | Buy |
| 200-day EMA: | 2.14 | Buy |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 60.61 | Buy |
| Chaikin Money Flow: | 1916381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.02 - 2.3) | Buy |
| Bollinger Bands (100): | (1.77 - 2.33) | Buy |
Esperion Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 2.41 while ESPR 8-day simple moving average is 2.30, which is a Buy signal.
- The stock price of ESPR is 2.41 while Esperion Therapeutics 20-day SMA is 2.18, which makes it a Buy.
- Esperion Therapeutics 50-day simple moving average is 1.99 while ESPR share price is 2.41, making it a Buy technically.
- ESPR stock price is 2.41 and Esperion Therapeutics 200-day simple moving average is 2.22, creating a Buy signal.
ESPR Technical Analysis vs Fundamental Analysis
Buy
52
Esperion Therapeutics (ESPR)
is a Buy
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a Buy
The current Esperion Therapeutics [ESPR] share price is $2.41. The Score for ESPR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
474.85M
Price in USD:
2.41
Share Volume:
4.28M
Esperion Therapeutics 52-Week Range
52-Week High:
3.40
52-Week Low:
1.15
Buy
52
Esperion Therapeutics (ESPR)
is a Buy
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?
The Esperion Therapeutics stock price is 2.41 USD today. -
Will ESPR stock go up or go down?
Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Esperion Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is not overvalued.
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 2.41 while ESPR 8-day exponential moving average is 2.28, which is a Buy signal.
- The stock price of ESPR is 2.41 while Esperion Therapeutics 20-day EMA is 2.20, which makes it a Buy.
- Esperion Therapeutics 50-day exponential moving average is 2.09 while ESPR share price is 2.41, making it a Buy technically.
- ESPR stock price is 2.41 and Esperion Therapeutics 200-day simple moving average is 2.14, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.75 per share, and an increase next year of $0.61 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
- ESPR Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Esperion Therapeutics is a Buy
- Esperion Therapeutics Relative Strength Index (RSI) is 60.61, which suggest Esperion Therapeutics is overbought
- The Bollinger Bands (25) for Esperion Therapeutics is (2.02 - 2.3), which suggest Esperion Therapeutics is a Buy
- The Bollinger Bands (100) for Esperion Therapeutics is (1.77 - 2.33), which suggest Esperion Therapeutics is a Buy
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.